Patents by Inventor Henrik Oestergaard

Henrik Oestergaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240093126
    Abstract: Detergent compositions including polypeptide variants and methods of cleaning and/or treatment of surfaces using such compositions, and fabric treatment compositions including polypeptide variants. The compositions may include surfactants: anionic, nonionic and/or cationic.
    Type: Application
    Filed: May 3, 2022
    Publication date: March 21, 2024
    Inventors: Lars BEIER, Lars Henrik OESTERGAARD, Annette Helle JOHANSEN, Klaus GORI, Thomas Holberg BLICHER, Gernot J. ABEL, Steen KROGSGAARD, Jens E NIELSEN, Lars GIGER, Neil Joseph LANT
  • Publication number: 20240060061
    Abstract: The present invention relates to polypeptide variants having DNase activity, as well as detergent compositions comprising the variants, use of the variants for cleaning, and methods for obtaining the variants.
    Type: Application
    Filed: March 10, 2022
    Publication date: February 22, 2024
    Applicant: Novozymes A/S
    Inventors: Marco Malten, Annette Helle Johansen, Lars Henrik Oestergaard, Lars Lehmann Hylling Christensen, Christian Berg Oehlenschlaeger
  • Publication number: 20230416706
    Abstract: The present invention relates to polypeptide variants and methods for obtaining variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: October 26, 2018
    Publication date: December 28, 2023
    Applicant: Novozymes A/S
    Inventors: Lars Beier, Klaus Gori, Lars Henrik Oestergaard, Lars Giger, Annette Helle Johansen, Gernot J. Abel
  • Publication number: 20230332122
    Abstract: The present invention relates to polypeptide variants and methods for obtaining variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: June 28, 2023
    Publication date: October 19, 2023
    Applicant: Novozymes A/S
    Inventors: Lars Henrik Oestergaard, Gernot J. Abel, Dorte Marie Koefoed Klitgaard, Annette Helle Johansen
  • Patent number: 11732252
    Abstract: The present invention relates to polypeptide variants and methods for obtaining variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: November 19, 2021
    Date of Patent: August 22, 2023
    Assignee: Novozymes A/S
    Inventors: Lars Henrik Oestergaard, Gernot J. Abel, Dorte Marie Koefoed Klitgaard, Annette Helle Johansen
  • Patent number: 11732220
    Abstract: Cleaning compositions may include novel dispersin variants having improved properties relative to the parent dispersin. Such properties may include one or more of the following; wash performance, stability e.g. detergent and/or storage stability. The cleaning compositions may be suitable for use in cleaning processes and include detergent compositions, such as laundry compositions and dish wash compositions, including hand wash and automatic dish wash compositions.
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: August 22, 2023
    Assignee: Henkel AG & Co. KGaA
    Inventors: Mirko Weide, Susanne Wieland, Lars Henrik Oestergaard, Annette Helle Johansen, Steffen Danielsen, Roland Alexander Pache, Johanne Moerch Jensen, Frank Winther Rasmussen, Martin Gudmand, Kasper Damgaard Tidemand
  • Publication number: 20230058721
    Abstract: The present invention relates to multispecific procoagulant antibodies capable of binding to coagulation Factor IX (FIX) and/or the activated form thereof Factor IXa (FIXa), and Factor X (FX) and/or the activated form thereof Factor Xa (FXa) and promoting FX activation by FIXa, antibodies binding their epitopes or parts thereof and methods and composition for treating subjects suffering from a coagulopathy such as haemophilia A as well as kits, methods of manufacture and methods of use.
    Type: Application
    Filed: November 10, 2021
    Publication date: February 23, 2023
    Inventors: Karina Thorn, Bjarne Gram Hansen, Laust Bruun Johnsen, Mikkel Nors Harndahl, Zhiru Yang, Henrik Oestergaard, Per J. Greisen, Eva Johansson, Morten Groenbech Rasch, Jianhe Chen, Anders Svensson, Haisun Zhu, Rong Zhou, Prafull S. Gandhi
  • Publication number: 20220364138
    Abstract: The present invention relates to polypeptide variants and methods for obtaining variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: April 6, 2020
    Publication date: November 17, 2022
    Applicant: Novozymes A/S
    Inventors: Lars Henrik Oestergaard, Annette Helle Johansen, Steffen Danielsen, Roland Alexander Pache, Johanne Moerch Jensen, Frank Winther Rasmussen, Martin Gudmand, Kasper Damgaard Tidemand
  • Patent number: 11447723
    Abstract: The present invention relates to polypeptide variants and methods for obtaining variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: September 20, 2022
    Assignee: NOVOZYMES A/S
    Inventors: Lars Beier, Lars Henrik Oestergaard, Annette Helle Johansen, Klaus Gori, Thomas Holberg Blicher, Gernot Abel, Steen Krogsgaard, Jens E. Nielsen, Lars Giger
  • Patent number: 11441136
    Abstract: The present invention relates to polypeptide variants and methods for obtaining variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: September 13, 2022
    Assignee: Novozymes A/S
    Inventors: Lars Henrik Oestergaard, Lars Giger, Annette Helle Johansen, Lars Beier, Jurgen Carsten Franz Knotzel, Gernot J. Abel, Klaus Gori
  • Publication number: 20220282187
    Abstract: Detergent compositions including polypeptide variants and methods of cleaning and/or treatment of surfaces using such compositions, and fabric treatment compositions including polypeptide variants. The compositions may include surfactants: anionic, nonionic and/or cationic.
    Type: Application
    Filed: May 3, 2022
    Publication date: September 8, 2022
    Inventors: Lars BEIER, Lars Henrik OESTERGAARD, Annette Helle JOHANSEN, Klaus GORI, Thomas Holberg BLICHER, Gernot J. ABEL, Steen KROGSGAARD, Jens E NIELSEN, Lars GIGER, Neil Joseph LANT
  • Publication number: 20220213218
    Abstract: The invention relates to a bispecific antibody comprising a first antigen-binding site capable of binding Factor VII(a) and a second antigen-binding site capable of binding TLT-1, pharmaceutical formulations comprising such bispecific antibodies and uses thereof.
    Type: Application
    Filed: March 21, 2022
    Publication date: July 7, 2022
    Inventors: Prafull S. Gandhi, Jens Breinholt, Henrik Oestergaard
  • Patent number: 11352592
    Abstract: Detergent compositions including polypeptide variants and methods of cleaning and/or treatment of surfaces using such compositions, and fabric treatment compositions including polypeptide variants. The compositions may include surfactants: anionic, nonionic and/or cationic.
    Type: Grant
    Filed: January 3, 2019
    Date of Patent: June 7, 2022
    Assignee: The Procter & Gamble Company
    Inventors: Lars Beier, Lars Henrik Oestergaard, Annette Helle Johansen, Klaus Gori, Thomas Holberg Blicher, Gernot J. Abel, Steen Krogsgaard, Jens E Nielsen, Lars Giger, Neil Joseph Lant
  • Patent number: 11325983
    Abstract: The invention relates to a bispecific antibody comprising a first antigen-binding site capable of binding Factor VII(a) and a second antigen-binding site capable of binding TLT-1, pharmaceutical formulations comprising such bispecific antibodies and uses thereof.
    Type: Grant
    Filed: October 14, 2021
    Date of Patent: May 10, 2022
    Assignee: Novo Nordisk A/S
    Inventors: Prafull S. Gandhi, Jens Breinholt, Henrik Oestergaard
  • Publication number: 20220073895
    Abstract: The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as polynucleotide constructs encoding such variants, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: April 12, 2021
    Publication date: March 10, 2022
    Inventors: Henrik Oestergaard, Ole Hvilsted Olsen, Katrine Skaarup Larsen, Henning Stennicke
  • Publication number: 20220064614
    Abstract: The present invention relates to polypeptide variants and methods for obtaining variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: November 19, 2021
    Publication date: March 3, 2022
    Applicant: Novozymes A/S
    Inventors: Lars Henrik Oestergaard, Gernot J. Abel, Dorte Marie Koefoed Klitgaard, Annette Helle Johansen
  • Publication number: 20220064329
    Abstract: The invention relates to a bispecific antibody comprising a first antigen-binding site capable of binding Factor VII(a) and a second antigen-binding site capable of binding TLT-1, pharmaceutical formulations comprising such bispecific antibodies and uses thereof.
    Type: Application
    Filed: October 14, 2021
    Publication date: March 3, 2022
    Inventors: Prafull S. Gandhi, Jens Breinholt, Henrik Oestergaard
  • Patent number: 11220554
    Abstract: The present invention relates to multispecific procoagulant antibodies capable of binding to coagulation Factor IX (FIX) and/or the activated form thereof Factor IXa (FIXa), and Factor X (FX) and/or the activated form thereof Factor Xa (FXa) and promoting FX activation by FIXa, antibodies binding their epitopes or parts thereof and methods and composition for treating subjects suffering from a coagulopathy such as haemophilia A as well as kits, methods of manufacture and methods of use.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: January 11, 2022
    Assignee: Novo Nordisk A/S
    Inventors: Karina Thorn, Bjarne Gram Hansen, Laust Bruun Johnsen, Mikkel Nors Harndahl, Zhiru Yang, Henrik Oestergaard, Per J. Greisen, Eva Johansson, Morten Groenbech Rasch, Jianhe Chen, Anders Svensson, Haisun Zhu, Rong Zhou, Prafull S. Gandhi
  • Publication number: 20210388114
    Abstract: The present invention relates to improved procoagulant antibodies including bispecific antibodies capable of binding to coagulation Factor IX (FIX) or the activated form thereof Factor IXa (FIXa) and optionally Factor X (FX) and the activated form thereof Factor Xa (FXa) and promoting FX activation by FIXa, antibodies binding their epitopes and methods and composition for treating subjects suffering from a coagulopathy such as haemophilia A.
    Type: Application
    Filed: February 1, 2018
    Publication date: December 16, 2021
    Inventors: Karina Thorn, Bjarne Gram Hansen, Laust Bruun Johnsen, Mikkel Nors Harndahl, Zhiru Yang, Henrik Oestergaard, Per J. Greisen, Eva Johansson, Morten Groenbech Rasch, Jianhe Chen, Anders Svensson, Haisun Zhu, Rong Zhou, Prafull S. Gandhi
  • Publication number: 20210317387
    Abstract: Cleaning compositions may include novel dispersin variants having improved properties relative to the parent dispersin. Such properties may include one or more of the following; wash performance, stability e.g. detergent and/or storage stability. The cleaning compositions may be suitable for use in cleaning processes and include detergent compositions, such as laundry compositions and dish wash compositions, including hand wash and automatic dish wash compositions.
    Type: Application
    Filed: March 29, 2021
    Publication date: October 14, 2021
    Inventors: Mirko WEIDE, Susanne WIELAND, Lars Henrik OESTERGAARD, Annette Helle JOHANSEN, Steffen DANIELSEN, Roland Alexander PACHE, Johanne Moerch JENSEN, Frank Winther RASMUSSEN, Martin GUDMAND, Kasper Damgaard TIDEMAND